A1RE34 Stock Overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Alexandria Real Estate Equities, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$150.15 |
| 52 Week High | US$179.28 |
| 52 Week Low | US$128.31 |
| Beta | 1.18 |
| 11 Month Change | -10.96% |
| 3 Month Change | -9.69% |
| 1 Year Change | 18.10% |
| 33 Year Change | -48.45% |
| 5 Year Change | n/a |
| Change since IPO | -12.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| A1RE34 | BR Health Care REITs | BR Market | |
|---|---|---|---|
| 7D | -5.2% | 0.1% | 0.3% |
| 1Y | 18.1% | 31.2% | -1.7% |
Return vs Industry: A1RE34 underperformed the BR Health Care REITs industry which returned 31.2% over the past year.
Return vs Market: A1RE34 exceeded the BR Market which returned -1.7% over the past year.
Price Volatility
| A1RE34 volatility | |
|---|---|
| A1RE34 Average Weekly Movement | 4.1% |
| Health Care REITs Industry Average Movement | 3.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.3% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: A1RE34 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: A1RE34's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 568 | Peter Moglia | www.are.com |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects.
Alexandria Real Estate Equities, Inc. Fundamentals Summary
| A1RE34 fundamental statistics | |
|---|---|
| Market cap | R$105.25b |
| Earnings (TTM) | R$1.63b |
| Revenue (TTM) | R$17.81b |
64.5x
P/E Ratio5.9x
P/S RatioIs A1RE34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A1RE34 income statement (TTM) | |
|---|---|
| Revenue | US$3.09b |
| Cost of Revenue | US$891.56m |
| Gross Profit | US$2.19b |
| Other Expenses | US$1.91b |
| Earnings | US$282.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.62 |
| Gross Margin | 71.10% |
| Net Profit Margin | 9.16% |
| Debt/Equity Ratio | 55.9% |
How did A1RE34 perform over the long term?
See historical performance and comparison